MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser

Completed
Conditions
Breast Cancer
Radiation-Induced Telangiectasias
Interventions
Behavioral: questionnaires
First Posted Date
2013-03-04
Last Posted Date
2018-02-07
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
22
Registration Number
NCT01803516
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer

Phase 1
Completed
Conditions
Metastatic Colorectal Cancer
Interventions
Drug: combination panitumumab and vemurafenib
First Posted Date
2013-02-13
Last Posted Date
2016-01-05
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
16
Registration Number
NCT01791309
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Recruiting
Conditions
Breast Cancer
Lymphoma
Hodgkin's Lymphoma
Interventions
Behavioral: surveys
Other: Blood draw
Device: Transvaginal ultrasounds
First Posted Date
2013-02-11
Last Posted Date
2024-01-24
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
400
Registration Number
NCT01788839
Locations
🇺🇸

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Westchester, Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 4 locations

Genomic Profiling in Cancer Patients

Recruiting
Conditions
Solid Tumors
Hematologic Cancers
Interventions
Genetic: molecular profiling of tumors
Genetic: Clinical Germline Analysis
First Posted Date
2013-01-24
Last Posted Date
2024-11-12
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
200
Registration Number
NCT01775072
Locations
🇺🇸

Norwalk Hospital, Norwalk, Connecticut, United States

🇺🇸

Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

🇺🇸

Lehigh Valley Health Network, Allentown, Pennsylvania, United States

and more 15 locations

Group Interventions for Breast Cancer Survivors

Not Applicable
Active, not recruiting
Conditions
Breast Cancer Survivor
Interventions
Behavioral: manualized group intervention
Behavioral: standardized, manualized group intervention
First Posted Date
2013-01-24
Last Posted Date
2024-02-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
104
Registration Number
NCT01775085
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical and Histopathologic Characteristics of BAP1 Mutations

Completed
Conditions
Primary Uveal Melanoma (UM)
Choroidal Nevus
Metastatic Uveal Melanoma (UM)
Renal Cell Carcinoma
Malignant Pleural Mesothelioma (MPM)
Cholangiocarcinoma
Interventions
Other: tumor specimens
First Posted Date
2013-01-23
Last Posted Date
2020-07-01
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
196
Registration Number
NCT01773655
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester, Harrison, New York, United States

Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
Drug: 89Zr- DFO-MSTP2109A
Drug: 89Zr DFO-MSTP2109A
First Posted Date
2013-01-23
Last Posted Date
2024-10-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
19
Registration Number
NCT01774071
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2
Active, not recruiting
Conditions
Fallopian Tubes Cancer
Ovarian Cancer
Peritoneal Cancer
Interventions
Procedure: Secondary Cytoreductive Surgery
Drug: Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Drug: platinum-based systemic chemotherapy postoperatively
First Posted Date
2013-01-14
Last Posted Date
2024-02-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
99
Registration Number
NCT01767675
Locations
🇺🇸

Memorial Sloan Kettering Commack, Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 8 locations

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

Phase 1
Completed
Conditions
Lung Cancer
Interventions
Biological: GL-ONC1
First Posted Date
2013-01-11
Last Posted Date
2024-10-26
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
18
Registration Number
NCT01766739
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Not Applicable
Completed
Conditions
Cancer Patients First-ever Acute Ischemic Stroke
Interventions
First Posted Date
2013-01-09
Last Posted Date
2020-08-14
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
20
Registration Number
NCT01763606
Locations
🇺🇸

New York Presbyterian Hospital, New York, New York, United States

🇺🇸

Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering West Harrison, Harrison, New York, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath